Catherine BARRIERE

Maitre de Conférences
institute
AccueilCatherine BARRIERE

Publications

15 publications
2022

L1 chimeric transcripts are expressed in healthy brain and their deregulation in glioma follows that of their host locus.

Publié le 17 Août 2022 dans Human molecular genetics , vol. 31 - pp 2606-2622

Pinson ME , Court F , Masson A , Renaud Y , Fantini A , Bacoeur-Ouzillou O, Barriere M, Pereira B, Guichet PO, Chautard E, Karayan-Tapon L, Verrelle P, Arnaud P , Vaurs-Barrière C

2021

Widespread overexpression from the four DNA hypermethylated HOX clusters in aggressive (IDHwt) glioma is associated with H3K27me3 depletion and alternative promoter usage.

Publié le 30 Août 2021 dans Molecular oncology , vol. 15 - pp 1995-2010

Le Boiteux E , Court F , Guichet PO, Vaurs-Barrière C , Vaillant I , Chautard E, Verrelle P, Costa BM, Karayan-Tapon L, Fogli A , Arnaud P

DNA
Gliome
H3K27me3
HOX
2019

Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanisms.

Publié le 30 Oct 2019 dans Genome research , vol. 29 - pp 1605-1621

Court F , Le Boiteux E , Fogli A , Müller-Barthélémy M, Vaurs-Barrière C , Chautard E, Pereira B, Biau J, Kemeny JL, Khalil T, Karayan-Tapon L, Verrelle P, Arnaud P

2018

Oxidative stress and mitochondrial dynamics malfunction are linked in Pelizaeus-Merzbacher disease.

Publié le 30 Sep 2018 dans Brain pathology (Zurich, Switzerland) , vol. 28 - pp 611-630

Ruiz M, Bégou M, Launay N, Ranea-Robles P, Bianchi P, López-Erauskin J, Morató L, Guilera C, Petit B, Vaurs-Barriere C , Guéret-Gonthier C, Bonnet-Dupeyron MN, Fourcade S, Auwerx J, Boespflug-Tanguy O, Pujol A

CLIFinder: identification of LINE-1 chimeric transcripts in RNA-seq data.

Publié le 15 Fév 2018 dans Bioinformatics (Oxford, England) , vol. 34 - pp 688-690

Pinson ME , Pogorelcnik R , Court F , Arnaud P , Vaurs-Barrière C

2017

Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosis.

Publié le 30 Nov 2017 dans Journal of neuro-oncology , vol. 135 - pp 381-390

Fogli A , Demattei MV, Corset L, Vaurs-Barrière C , Chautard E, Biau J, Kémény JL, Godfraind C, Pereira B, Khalil T, Grandin N , Arnaud P , Charbonneau M , Verrelle P

2016

The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients’ survival.

Publié le 01 Mar 2016 dans Carcinogenesis , vol. 37 - pp 169-176

Fogli A , Chautard E, Vaurs-Barrière C , Pereira B, Müller-Barthélémy M, Court F , Biau J, Pinto AA, Kémény JL, Khalil T, Karayan-Tapon L, Verrelle P, Costa BM, Arnaud P

2013

Fluorescent mRNA labeling through cytoplasmic FISH.

Publié le 30 Déc 2013 dans Nature protocols , vol. 8 - pp 2538-47

Gasnier M , Dennis C , Vaurs-Barrière C , Chazaud C

2012

Sjögren-Larsson syndrome: novel mutations in the ALDH3A2 gene in a French cohort.

Publié le 15 Jan 2012 dans Journal of the neurological sciences , vol. 312 - pp 123-6

Sarret C, Rigal M , Vaurs-Barrière C , Dorboz I, Eymard-Pierre E, Combes P, Giraud G , Wanders RJ, Afenjar A, Francannet C, Boespflug-Tanguy O

Relevance of GJC2 promoter mutation in Pelizaeus-Merzbacher-like disease.

Publié le 30 Jan 2012 dans Annals of neurology , vol. 71 - pp 146-8

Combes P, Kammoun N, Monnier A, Gonthier-Guéret C, Giraud G , Bertini E, Chahnez T, Fakhfakh F, Boespflug-Tanguy O, Vaurs-Barrière C

2011

Molecular genetic analysis of the PLP1 gene in 38 families with PLP1-related disorders: identification and functional characterization of 11 novel PLP1 mutations.

Publié le 16 Juin 2011 dans Orphanet journal of rare diseases , vol. 6 - pp 40

Grossi S, Regis S, Biancheri R, Mort M, Lualdi S, Bertini E, Uziel G, Boespflug-Tanguy O, Simonati A, Corsolini F, Demir E, Marchiani V, Percesepe A, Stanzial F, Rossi A, Vaurs-Barrière C , Cooper DN, Filocamo M

Neurodegenerative disorder related to AIMP1/p43 mutation is not a PMLD.

Publié le 11 Mar 2011 dans American journal of human genetics , vol. 88 - pp 392-3; author reply 393-5

Boespflug-Tanguy O, Aubourg P, Dorboz I, Bégou M, Giraud G , Sarret C, Vaurs-Barrière C

2009

Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects.

Publié le 30 Jan 2009 dans Annals of neurology , vol. 65 - pp 114-8

Vaurs-Barrière C , Deville M, Sarret C, Giraud G , Des Portes V, Prats-Viñas JM, De Michele G, Dan B, Brady AF, Boespflug-Tanguy O, Touraine R

2008

Absence of OLIG2 mutations in patients presenting with a severe Pelizaeus-Merzbacher-like leukodystrophy associated with motor neuron dysfunction.

Publié le 05 Juin 2008 dans American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics , vol. 147B - pp 538-9

Bonnet-Dupeyron MN, Combes P, Boespflug-Tanguy O, Vaurs-Barrière C

PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.

Publié le 30 Août 2008 dans Human mutation , vol. 29 - pp 1028-36

Bonnet-Dupeyron MN, Combes P, Santander P, Cailloux F, Boespflug-Tanguy O, Vaurs-Barrière C

Contacter
Catherine BARRIERE

    logo-europe
    logo-region-auvergne
    logo-cnrs
    logo-uca
    Inserm_rvb_noir
    iGReD
    Votre navigateur est obsolète

    Pour profiter du site,
    merci de mettre à jour votre navigateur